These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9744120)

  • 1. Detection of drug use in a methadone maintenance clinic: sweat patches versus urine testing.
    Taylor JR; Watson ID; Tames FJ; Lowe D
    Addiction; 1998 Jun; 93(6):847-53. PubMed ID: 9744120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous liquid chromatography-mass spectrometry quantification of urinary opiates, cocaine, and metabolites in opiate-dependent pregnant women in methadone-maintenance treatment.
    Shakleya DM; Dams R; Choo RE; Jones H; Huestis MA
    J Anal Toxicol; 2010; 34(1):17-25. PubMed ID: 20109298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sweat testing in addicts under methadone treatment: an Italian experience.
    Fucci N; De Giovanni N; Scarlata S
    Forensic Sci Int; 2008 Jan; 174(2-3):107-10. PubMed ID: 17428631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence.
    Chawarski MC; Fiellin DA; O'Connor PG; Bernard M; Schottenfeld RS
    J Subst Abuse Treat; 2007 Dec; 33(4):411-5. PubMed ID: 17512157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immunoassays for semiquantitative detection of cocaine and metabolites or heroin and metabolites in extracts of sweat patches.
    Moody DE; Cheever ML
    J Anal Toxicol; 2001 Apr; 25(3):190-7. PubMed ID: 11327351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring pregnant women's illicit opiate and cocaine use with sweat testing.
    Brunet BR; Barnes AJ; Choo RE; Mura P; Jones HE; Huestis MA
    Ther Drug Monit; 2010 Feb; 32(1):40-9. PubMed ID: 19927046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sweat testing in opioid users with a sweat patch.
    Kintz P; Tracqui A; Mangin P; Edel Y
    J Anal Toxicol; 1996 Oct; 20(6):393-7. PubMed ID: 8889674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring outcome in cocaine clinical trials: a comparison of sweat patches with urine toxicology and participant self-report.
    Winhusen TM; Somoza EC; Singal B; Kim S; Horn PS; Rotrosen J
    Addiction; 2003 Mar; 98(3):317-24. PubMed ID: 12603231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing.
    Preston KL; Huestis MA; Wong CJ; Umbricht A; Goldberger BA; Cone EJ
    J Anal Toxicol; 1999 Sep; 23(5):313-22. PubMed ID: 10488917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sweat testing to monitor drug exposure.
    Gambelunghe C; Rossi R; Aroni K; Bacci M; Lazzarini A; De Giovanni N; Carletti P; Fucci N
    Ann Clin Lab Sci; 2013; 43(1):22-30. PubMed ID: 23462602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone in hair and sweat from patients in long-term maintenance therapy.
    Fucci N; De Giovanni N
    Ther Drug Monit; 2007 Aug; 29(4):452-4. PubMed ID: 17667800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.
    Beck T; Haasen C; Verthein U; Walcher S; Schuler C; Backmund M; Ruckes C; Reimer J
    Addiction; 2014 Apr; 109(4):617-26. PubMed ID: 24304412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine toxicology screen negative for Methadone metabolite but positive for Methadone in a patient on Methadone maintenance therapy (MMT).
    Ravishankar DA; Calhoun E; Sethi R; Din A
    Asian J Psychiatr; 2020 Apr; 50():101969. PubMed ID: 32109808
    [No Abstract]   [Full Text] [Related]  

  • 15. Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
    Fischer G; Gombas W; Eder H; Jagsch R; Peternell A; Stühlinger G; Pezawas L; Aschauer HN; Kasper S
    Addiction; 1999 Sep; 94(9):1337-47. PubMed ID: 10615719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration.
    Barnes AJ; Brunet BR; Choo RE; Mura P; Johnson RE; Jones HE; Huestis MA
    Ther Drug Monit; 2010 Aug; 32(4):497-503. PubMed ID: 20592651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine abuse sharply reduced in an effective methadone maintenance program.
    Borg L; Broe DM; Ho A; Kreek MJ
    J Addict Dis; 1999; 18(4):63-75. PubMed ID: 10631964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs.
    Musshoff F; Trafkowski J; Lichtermann D; Madea B
    Int J Legal Med; 2010 Sep; 124(5):499-503. PubMed ID: 19672612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients.
    Margolin A; Kantak K; Copenhaver M; Avants SK
    J Addict Dis; 2003; 22(2):49-61. PubMed ID: 12703668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.